Quick Answer
Elanco Animal Health Inc reported Stockholders Equity of $6.55 billion for the year ending 2025.
- Elanco Animal Health Inc showed an increase of +7.4% in Stockholders Equity from 2024 to 2025.
- This data is from Elanco Animal Health Inc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $7.96 billion | Q1 2018: $7.90 billion | Q2 2018: $7.58 billion | Q3 2018: $5.14 billion | Q1 2019: $5.20 billion | Q2 2019: $5.27 billion | Q3 2019: $5.49 billion | Q1 2020: $6.66 billion | Q2 2020: $6.65 billion | Q3 2020: $8.34 billion | Q1 2021: $8.01 billion | Q2 2021: $7.98 billion | Q3 2021: $7.68 billion | Q1 2022: $7.59 billion | Q2 2022: $7.13 billion | Q3 2022: $6.71 billion | Q1 2023: $7.48 billion | Q2 2023: $7.42 billion | Q3 2023: $6.13 billion | Q1 2024: $6.06 billion | Q2 2024: $5.94 billion | Q3 2024: $6.52 billion | Q1 2025: $6.35 billion | Q2 2025: $6.78 billion | Q3 2025: $6.75 billion.
- Over the full 11 years of available data (2015 to 2025), Elanco Animal Health Inc's Stockholders Equity has declined by 11.9%.
- Historical annual values: Fiscal year 2025: $6.55 billion | Fiscal year 2024: $6.10 billion | Fiscal year 2023: $6.22 billion | Fiscal year 2022: $7.29 billion | Fiscal year 2021: $7.51 billion | Fiscal year 2020: $8.46 billion | Fiscal year 2019: $5.54 billion | Fiscal year 2018: $5.20 billion | Fiscal year 2017: $7.78 billion | Fiscal year 2016: $7.02 billion | Fiscal year 2015: $7.43 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: